T1 and T2 Mapping

Tempus AI Secures FDA 510(k) Clearance for Upgraded Pixel Cardiac Imaging, Stock Jumps

The decision validates new inline T1/T2 mapping from raw MRI data that Tempus says can speed cardiac assessments.